Global Oxycodone Drug Market

Oxycodone Drug Comprehensive Study by Distribution Channel (Online {Company Website, E-Commerce Website}, Offline {Pharma Stores, Local Medical Stores}), End Use (Hospitals, Clinics, Diagnostic Centers), Dosage Forms (Capsule, Tablet, Liquid), Side Effects (Dry Mouth, Stomach Pain, Drowsiness, Flushing, Headache, Other) Players and Region - Global Market Outlook to 2027

Oxycodone Drug Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Oxycodone Drug Market Scope?
Oxycontin (oxycodone hydrochloride) is an opioid medication used to treat moderate to severe pain over a long length of time. Oxycontin is not a "pain-as-needed" (PRN) medication. Oxycontin is a generic medication that is available. Alcohol, other narcotic pain relievers, sedatives, tranquillizers, sleeping pills, muscle relaxers, other medicines that make you sleepy or slow your breathing, monoamine oxidase inhibitors (MAOIs), antidepressants, methscopolamine, scopolamine, bladder or urinary medications, or irritable bowel medications may all interact with oxycodone. Mixed agonist/antagonist analgesics, macrolide antibiotics, azole-antifungals, protease inhibitors, rifampin, and cardiovascular medications may all interact with oxycodone (including amiodarone and quinidine). The dosages revised based on the degree of the ache and the patient's reactions.

The Oxycodone Drug market study is being classified and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Oxycodone Drug market throughout the predicted period.

Johnson & Johnson JNJ (United States), Pfizer (United States), Collegium Pharmaceutical Inc. (United States), Impax Laboratories (United States), Endo Pharmaceuticals Inc. (United States), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceuticals (Israel), Hikma Pharmaceuticals (United Kingdom), Mylan (United States) and Indivior (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Oxycodone Drug market by Type, Application and Region.

On the basis of geography, the market of Oxycodone Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

On 13 December 2021, Pfizer Inc. and Arena Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.


Influencing Market Trend
  • High Investment In Pharmaceuticals Industries
  • Governments Are Taking Initiatives To Boost The Production Of Oxycodone Drugs

Market Drivers
  • Increased Prevalence Of Cancer
  • Rise In Geriatric Population

Opportunities
  • Growing The Number Of Trauma And Surgery Cases
  • Rapidly Expansion Of Pharmaceutical Industry

Restraints
  • Side-Effects Of Oxycodone Drugs Such As Headache, And Stomach Pain

Challenges
  • High Price Of Product And Limited Production


Key Target Audience
Oxycodone Drug Provider, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Distribution Channel
  • Online {Company Website, E-Commerce Website}
  • Offline {Pharma Stores, Local Medical Stores}

By End Use
  • Hospitals
  • Clinics
  • Diagnostic Centers

By Dosage Forms
  • Capsule
  • Tablet
  • Liquid

By Side Effects
  • Dry Mouth
  • Stomach Pain
  • Drowsiness
  • Flushing
  • Headache
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence Of Cancer
      • 3.2.2. Rise In Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. High Price Of Product And Limited Production
    • 3.4. Market Trends
      • 3.4.1. High Investment In Pharmaceuticals Industries
      • 3.4.2. Governments Are Taking Initiatives To Boost The Production Of Oxycodone Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oxycodone Drug, by Distribution Channel, End Use, Dosage Forms, Side Effects and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Oxycodone Drug (Value)
      • 5.2.1. Global Oxycodone Drug by: Distribution Channel (Value)
        • 5.2.1.1. Online {Company Website, E-Commerce Website}
        • 5.2.1.2. Offline {Pharma Stores, Local Medical Stores}
      • 5.2.2. Global Oxycodone Drug by: End Use (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Diagnostic Centers
      • 5.2.3. Global Oxycodone Drug by: Dosage Forms (Value)
        • 5.2.3.1. Capsule
        • 5.2.3.2. Tablet
        • 5.2.3.3. Liquid
      • 5.2.4. Global Oxycodone Drug by: Side Effects (Value)
        • 5.2.4.1. Dry Mouth
        • 5.2.4.2. Stomach Pain
        • 5.2.4.3. Drowsiness
        • 5.2.4.4. Flushing
        • 5.2.4.5. Headache
        • 5.2.4.6. Other
      • 5.2.5. Global Oxycodone Drug Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Oxycodone Drug (Price)
  • 6. Oxycodone Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson JNJ (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Collegium Pharmaceutical Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Impax Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Endo Pharmaceuticals Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sun Pharmaceutical Industries Ltd (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Teva Pharmaceuticals (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hikma Pharmaceuticals (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mylan (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Indivior (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Oxycodone Drug Sale, by Distribution Channel, End Use, Dosage Forms, Side Effects and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Oxycodone Drug (Value)
      • 7.2.1. Global Oxycodone Drug by: Distribution Channel (Value)
        • 7.2.1.1. Online {Company Website, E-Commerce Website}
        • 7.2.1.2. Offline {Pharma Stores, Local Medical Stores}
      • 7.2.2. Global Oxycodone Drug by: End Use (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Diagnostic Centers
      • 7.2.3. Global Oxycodone Drug by: Dosage Forms (Value)
        • 7.2.3.1. Capsule
        • 7.2.3.2. Tablet
        • 7.2.3.3. Liquid
      • 7.2.4. Global Oxycodone Drug by: Side Effects (Value)
        • 7.2.4.1. Dry Mouth
        • 7.2.4.2. Stomach Pain
        • 7.2.4.3. Drowsiness
        • 7.2.4.4. Flushing
        • 7.2.4.5. Headache
        • 7.2.4.6. Other
      • 7.2.5. Global Oxycodone Drug Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Oxycodone Drug (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oxycodone Drug: by Distribution Channel(USD Million)
  • Table 2. Oxycodone Drug Online {Company Website, E-Commerce Website} , by Region USD Million (2016-2021)
  • Table 3. Oxycodone Drug Offline {Pharma Stores, Local Medical Stores} , by Region USD Million (2016-2021)
  • Table 4. Oxycodone Drug: by End Use(USD Million)
  • Table 5. Oxycodone Drug Hospitals , by Region USD Million (2016-2021)
  • Table 6. Oxycodone Drug Clinics , by Region USD Million (2016-2021)
  • Table 7. Oxycodone Drug Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 8. Oxycodone Drug: by Dosage Forms(USD Million)
  • Table 9. Oxycodone Drug Capsule , by Region USD Million (2016-2021)
  • Table 10. Oxycodone Drug Tablet , by Region USD Million (2016-2021)
  • Table 11. Oxycodone Drug Liquid , by Region USD Million (2016-2021)
  • Table 12. Oxycodone Drug: by Side Effects(USD Million)
  • Table 13. Oxycodone Drug Dry Mouth , by Region USD Million (2016-2021)
  • Table 14. Oxycodone Drug Stomach Pain , by Region USD Million (2016-2021)
  • Table 15. Oxycodone Drug Drowsiness , by Region USD Million (2016-2021)
  • Table 16. Oxycodone Drug Flushing , by Region USD Million (2016-2021)
  • Table 17. Oxycodone Drug Headache , by Region USD Million (2016-2021)
  • Table 18. Oxycodone Drug Other , by Region USD Million (2016-2021)
  • Table 19. South America Oxycodone Drug, by Country USD Million (2016-2021)
  • Table 20. South America Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 21. South America Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 22. South America Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 23. South America Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 24. Brazil Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 25. Brazil Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 26. Brazil Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 27. Brazil Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 28. Argentina Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 29. Argentina Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 30. Argentina Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 31. Argentina Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 32. Rest of South America Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 33. Rest of South America Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 34. Rest of South America Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 35. Rest of South America Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 36. Asia Pacific Oxycodone Drug, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 38. Asia Pacific Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 39. Asia Pacific Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 40. Asia Pacific Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 41. China Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 42. China Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 43. China Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 44. China Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 45. Japan Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 46. Japan Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 47. Japan Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 48. Japan Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 49. India Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 50. India Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 51. India Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 52. India Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 53. South Korea Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 54. South Korea Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 55. South Korea Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 56. South Korea Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 57. Australia Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 58. Australia Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 59. Australia Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 60. Australia Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 65. Europe Oxycodone Drug, by Country USD Million (2016-2021)
  • Table 66. Europe Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 67. Europe Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 68. Europe Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 69. Europe Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 70. Germany Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 71. Germany Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 72. Germany Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 73. Germany Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 74. France Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 75. France Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 76. France Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 77. France Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 78. Italy Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 79. Italy Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 80. Italy Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 81. Italy Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 82. United Kingdom Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 83. United Kingdom Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 84. United Kingdom Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 85. United Kingdom Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 86. Netherlands Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 87. Netherlands Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 88. Netherlands Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 89. Netherlands Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 90. Rest of Europe Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 91. Rest of Europe Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 92. Rest of Europe Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 93. Rest of Europe Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 94. MEA Oxycodone Drug, by Country USD Million (2016-2021)
  • Table 95. MEA Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 96. MEA Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 97. MEA Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 98. MEA Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 99. Middle East Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 100. Middle East Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 101. Middle East Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 102. Middle East Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 103. Africa Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 104. Africa Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 105. Africa Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 106. Africa Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 107. North America Oxycodone Drug, by Country USD Million (2016-2021)
  • Table 108. North America Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 109. North America Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 110. North America Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 111. North America Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 112. United States Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 113. United States Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 114. United States Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 115. United States Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 116. Canada Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 117. Canada Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 118. Canada Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 119. Canada Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 120. Mexico Oxycodone Drug, by Distribution Channel USD Million (2016-2021)
  • Table 121. Mexico Oxycodone Drug, by End Use USD Million (2016-2021)
  • Table 122. Mexico Oxycodone Drug, by Dosage Forms USD Million (2016-2021)
  • Table 123. Mexico Oxycodone Drug, by Side Effects USD Million (2016-2021)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Oxycodone Drug: by Distribution Channel(USD Million)
  • Table 135. Oxycodone Drug Online {Company Website, E-Commerce Website} , by Region USD Million (2022-2027)
  • Table 136. Oxycodone Drug Offline {Pharma Stores, Local Medical Stores} , by Region USD Million (2022-2027)
  • Table 137. Oxycodone Drug: by End Use(USD Million)
  • Table 138. Oxycodone Drug Hospitals , by Region USD Million (2022-2027)
  • Table 139. Oxycodone Drug Clinics , by Region USD Million (2022-2027)
  • Table 140. Oxycodone Drug Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 141. Oxycodone Drug: by Dosage Forms(USD Million)
  • Table 142. Oxycodone Drug Capsule , by Region USD Million (2022-2027)
  • Table 143. Oxycodone Drug Tablet , by Region USD Million (2022-2027)
  • Table 144. Oxycodone Drug Liquid , by Region USD Million (2022-2027)
  • Table 145. Oxycodone Drug: by Side Effects(USD Million)
  • Table 146. Oxycodone Drug Dry Mouth , by Region USD Million (2022-2027)
  • Table 147. Oxycodone Drug Stomach Pain , by Region USD Million (2022-2027)
  • Table 148. Oxycodone Drug Drowsiness , by Region USD Million (2022-2027)
  • Table 149. Oxycodone Drug Flushing , by Region USD Million (2022-2027)
  • Table 150. Oxycodone Drug Headache , by Region USD Million (2022-2027)
  • Table 151. Oxycodone Drug Other , by Region USD Million (2022-2027)
  • Table 152. South America Oxycodone Drug, by Country USD Million (2022-2027)
  • Table 153. South America Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 154. South America Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 155. South America Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 156. South America Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 157. Brazil Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 158. Brazil Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 159. Brazil Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 160. Brazil Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 161. Argentina Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 162. Argentina Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 163. Argentina Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 164. Argentina Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 165. Rest of South America Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 166. Rest of South America Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 167. Rest of South America Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 168. Rest of South America Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 169. Asia Pacific Oxycodone Drug, by Country USD Million (2022-2027)
  • Table 170. Asia Pacific Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 171. Asia Pacific Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 172. Asia Pacific Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 173. Asia Pacific Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 174. China Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 175. China Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 176. China Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 177. China Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 178. Japan Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 179. Japan Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 180. Japan Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 181. Japan Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 182. India Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 183. India Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 184. India Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 185. India Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 186. South Korea Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 187. South Korea Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 188. South Korea Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 189. South Korea Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 190. Australia Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 191. Australia Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 192. Australia Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 193. Australia Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 194. Rest of Asia-Pacific Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 195. Rest of Asia-Pacific Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 196. Rest of Asia-Pacific Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 197. Rest of Asia-Pacific Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 198. Europe Oxycodone Drug, by Country USD Million (2022-2027)
  • Table 199. Europe Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 200. Europe Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 201. Europe Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 202. Europe Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 203. Germany Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 204. Germany Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 205. Germany Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 206. Germany Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 207. France Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 208. France Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 209. France Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 210. France Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 211. Italy Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 212. Italy Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 213. Italy Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 214. Italy Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 215. United Kingdom Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 216. United Kingdom Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 217. United Kingdom Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 218. United Kingdom Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 219. Netherlands Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 220. Netherlands Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 221. Netherlands Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 222. Netherlands Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 223. Rest of Europe Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 224. Rest of Europe Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 225. Rest of Europe Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 226. Rest of Europe Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 227. MEA Oxycodone Drug, by Country USD Million (2022-2027)
  • Table 228. MEA Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 229. MEA Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 230. MEA Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 231. MEA Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 232. Middle East Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 233. Middle East Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 234. Middle East Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 235. Middle East Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 236. Africa Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 237. Africa Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 238. Africa Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 239. Africa Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 240. North America Oxycodone Drug, by Country USD Million (2022-2027)
  • Table 241. North America Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 242. North America Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 243. North America Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 244. North America Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 245. United States Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 246. United States Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 247. United States Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 248. United States Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 249. Canada Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 250. Canada Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 251. Canada Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 252. Canada Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 253. Mexico Oxycodone Drug, by Distribution Channel USD Million (2022-2027)
  • Table 254. Mexico Oxycodone Drug, by End Use USD Million (2022-2027)
  • Table 255. Mexico Oxycodone Drug, by Dosage Forms USD Million (2022-2027)
  • Table 256. Mexico Oxycodone Drug, by Side Effects USD Million (2022-2027)
  • Table 257. Research Programs/Design for This Report
  • Table 258. Key Data Information from Secondary Sources
  • Table 259. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oxycodone Drug: by Distribution Channel USD Million (2016-2021)
  • Figure 5. Global Oxycodone Drug: by End Use USD Million (2016-2021)
  • Figure 6. Global Oxycodone Drug: by Dosage Forms USD Million (2016-2021)
  • Figure 7. Global Oxycodone Drug: by Side Effects USD Million (2016-2021)
  • Figure 8. South America Oxycodone Drug Share (%), by Country
  • Figure 9. Asia Pacific Oxycodone Drug Share (%), by Country
  • Figure 10. Europe Oxycodone Drug Share (%), by Country
  • Figure 11. MEA Oxycodone Drug Share (%), by Country
  • Figure 12. North America Oxycodone Drug Share (%), by Country
  • Figure 13. Global Oxycodone Drug share by Players 2021 (%)
  • Figure 14. Global Oxycodone Drug share by Players (Top 3) 2021(%)
  • Figure 15. Global Oxycodone Drug share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Johnson & Johnson JNJ (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson & Johnson JNJ (United States) Revenue: by Geography 2021
  • Figure 19. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pfizer (United States) Revenue: by Geography 2021
  • Figure 21. Collegium Pharmaceutical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Collegium Pharmaceutical Inc. (United States) Revenue: by Geography 2021
  • Figure 23. Impax Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Impax Laboratories (United States) Revenue: by Geography 2021
  • Figure 25. Endo Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Endo Pharmaceuticals Inc. (United States) Revenue: by Geography 2021
  • Figure 27. Sun Pharmaceutical Industries Ltd (India) Revenue, Net Income and Gross profit
  • Figure 28. Sun Pharmaceutical Industries Ltd (India) Revenue: by Geography 2021
  • Figure 29. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 30. Teva Pharmaceuticals (Israel) Revenue: by Geography 2021
  • Figure 31. Hikma Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Hikma Pharmaceuticals (United Kingdom) Revenue: by Geography 2021
  • Figure 33. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 34. Mylan (United States) Revenue: by Geography 2021
  • Figure 35. Indivior (United States) Revenue, Net Income and Gross profit
  • Figure 36. Indivior (United States) Revenue: by Geography 2021
  • Figure 37. Global Oxycodone Drug: by Distribution Channel USD Million (2022-2027)
  • Figure 38. Global Oxycodone Drug: by End Use USD Million (2022-2027)
  • Figure 39. Global Oxycodone Drug: by Dosage Forms USD Million (2022-2027)
  • Figure 40. Global Oxycodone Drug: by Side Effects USD Million (2022-2027)
  • Figure 41. South America Oxycodone Drug Share (%), by Country
  • Figure 42. Asia Pacific Oxycodone Drug Share (%), by Country
  • Figure 43. Europe Oxycodone Drug Share (%), by Country
  • Figure 44. MEA Oxycodone Drug Share (%), by Country
  • Figure 45. North America Oxycodone Drug Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson JNJ (United States)
  • Pfizer (United States)
  • Collegium Pharmaceutical Inc. (United States)
  • Impax Laboratories (United States)
  • Endo Pharmaceuticals Inc. (United States)
  • Sun Pharmaceutical Industries Ltd (India)
  • Teva Pharmaceuticals (Israel)
  • Hikma Pharmaceuticals (United Kingdom)
  • Mylan (United States)
  • Indivior (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 207 Pages 72 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Oxycodone Drug Market Quantitative research analysis
Global Oxycodone Drug Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Oxycodone Drug market is expected to see a growth of % during projected year 2021 to 2027.
The prominent players of Global Oxycodone Drug market are Johnson & Johnson JNJ (United States), Pfizer (United States), Collegium Pharmaceutical Inc. (United States), Impax Laboratories (United States), Endo Pharmaceuticals Inc. (United States), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceuticals (Israel), Hikma Pharmaceuticals (United Kingdom), Mylan (United States) and Indivior (United States), to name a few.
In this highly competitive & fast evolving Oxycodone Drug industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Oxycodone Drug Market Report?

Have a Query? Click Here

Other Related Reports

Spiramycin Drug Comprehensive Study by Type (Oral route {Capsule, Tablets}, Rectal route {Suppository}, Injection route), Disease (Toxoplasmosis, Cryptosporidiosis), Distribution Channel (Hospital ph...
$ 3800
Argininemia Drugs- Comprehensive Study by Medications (Protein Intake Limited, Sodium Benzoate, Sodium Phenylbutyrate, Carglumic Acid, Others), Diagnosis (Plasma Ammonia Concentration, Urinary Orotic...
$ 3500
Perineural Therapy Comprehensive Study by Type (Internal Neurostimulation Devices {Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimulation, Spinal Cord Stimulation, Deep Bra...
$ 3800
Triptorelin Drug- Comprehensive Study by Application (Advanced prostate cancer, Endometriosis, Uterine fibroids, Precocious puberty), Doses Forms (3.75 mg Vial, 11.25 mg Vial, 22.5 mg Vial) Players a...
$ 3400
Quadriplegia Treatment Comprehensive Study by Administration (Oral, Intravenous, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores) Players and Region ...
$ 3400
Sleep Supplements Comprehensive Study by Prescription (Antidepressants, Benzodiazepines, Z-drugs (Ambien® and Lunesta®)), Form (Capsule, Liquid, Powder, Others), Distribution Channel (Hospital Pharm...
$ 3800